COPE
Volume 4, Number 3 (Jul 2016)                   Res Mol Med (RMM) 2016, 4(3): 3-9 | Back to browse issues page



DOI: 10.18869/acadpub.rmm.4.3.3

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadgholi M, Rezazadeh F, Sadeghzadeh N. Targeted Cancer Diagnostic and Therapeutic Agents: Delivery by Carriers or Conjugation. Res Mol Med (RMM). 2016; 4 (3) :3-9
URL: http://rmm.mazums.ac.ir/article-1-215-en.html

Abstract:   (677 Views)

Receptors and proteins are overexpressed in many human cancer cell membranes rather than normal tissues and are considered as the main molecular targets. Specific tumor- targeting molecules which have high affinity for these receptors can be valuable tools as carrier molecules for targeted cancer therapy and imaging. Pharmacokinetics and bioavailability of diagnostic and therapeutic agents are very important. Poor selectivity of cancer therapeutic agents causes toxicity on normal cells that limits maximum effective dose. The Attachment of these agents to macromolecules or their installation on carriers is currently under investigation. This article presents recent developments in the field of targeting agents and introduces different carriers and their applications in the diagnosis and treatment of cancer.

Full-Text [PDF 677 kb]   (150 Downloads)    
Type of Study: Research | Subject: Pharmacology
Received: 2016/11/2 | Accepted: 2016/12/31 | Published: 2016/12/31

Add your comments about this article : Your username or email:
Write the security code in the box

Send email to the article author


© 2015 All Rights Reserved | Research in Molecular Medicine

Designed & Developed by : Yektaweb